NCT06089577View on ClinicalTrials.gov

Effects of Cangrelor on MIcRovAscular Disfunction During Elective Percutaneous CORonary Intervention

PHASE4RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2026

Conditions
Coronary Artery Disease
Interventions
DRUG

Cangrelor 50 MG

Cangrelor will be administered during PCI

Trial Locations (2)

44124

NOT_YET_RECRUITING

Division of Cardiology, University Hospital of Ferrara, Ferrara

80131

RECRUITING

Division of Cardiology - Federico II University Hospital, Naples

All Listed Sponsors
lead

Federico II University

OTHER